{"id":10797,"date":"2026-01-13T14:30:00","date_gmt":"2026-01-13T14:30:00","guid":{"rendered":"https:\/\/www.bedfont.com\/?p=10797"},"modified":"2025-12-15T12:55:17","modified_gmt":"2025-12-15T12:55:17","slug":"nobreath-device-is-allergists-device-of-choice-in-the-usa","status":"publish","type":"post","link":"https:\/\/www.bedfont.com\/nl\/nobreath-device-is-allergists-device-of-choice-in-the-usa\/","title":{"rendered":"coVita&#x2122; and Allergy Partners team up to improve asthma care in America"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\"><strong><em>Innovative NObreath\u00ae FeNO device is the allergists&#8217; device of choice in the USA.<\/em><\/strong><\/h2>\n\n\n\n<p>coVita&#x2122; LLC, a leader in advanced breath analysis and diagnostic solutions, serves as the U.S. distributor for the innovative NObreath\u00ae Fractional Exhaled Nitric Oxide (FeNO) device from UK-based Bedfont\u00ae Scientific Ltd. The new agreement with Allergy Partners marks the culmination of a strategic partnership developed over the past two years.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><em>\u201cThe partnership established between coVita&#x2122; and Allergy Partners marks important progress in broadening access to FeNO technology on a global scale.\u201d<\/em> Said <strong>Jason Smith, CEO at Bedfont\u00ae.<\/strong> <em>\u201cWe are pleased to support this collaboration and proud of the role coVita&#x2122; is playing in advancing high-quality asthma care.\u201d<\/em><\/p>\n<\/blockquote>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/www.bedfont.com\/wp-content\/uploads\/2025\/12\/NObreath-Breath-Test-1024x683.png\" alt=\"NObreath\u00ae device is allergists' device of choice in the USA.\" class=\"wp-image-10799\" style=\"aspect-ratio:1.5000558066856409;width:465px;height:auto\" srcset=\"https:\/\/www.bedfont.com\/wp-content\/uploads\/2025\/12\/NObreath-Breath-Test-1024x683.png 1024w, https:\/\/www.bedfont.com\/wp-content\/uploads\/2025\/12\/NObreath-Breath-Test-300x200.png 300w, https:\/\/www.bedfont.com\/wp-content\/uploads\/2025\/12\/NObreath-Breath-Test-768x512.png 768w, https:\/\/www.bedfont.com\/wp-content\/uploads\/2025\/12\/NObreath-Breath-Test-1536x1024.png 1536w, https:\/\/www.bedfont.com\/wp-content\/uploads\/2025\/12\/NObreath-Breath-Test-2048x1365.png 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><figcaption class=\"wp-element-caption\">Taking a FeNO test with the NObreath\u00ae<\/figcaption><\/figure>\n<\/div>\n\n\n<p>As the nation\u2019s largest and most trusted integrated network of allergy and asthma specialists, Allergy Partners serves patients through more than 125 locations in over 20 states. Under the new agreement, all Allergy Partners clinics will provide FeNO testing with the NObreath\u00ae device, enhancing patient access to advanced, non-invasive tools that aid in asthma diagnosis and management. The NObreath\u00ae is the allergist&#8217;s device of choice in the USA, further underscoring its value in supporting accurate assessment and personalised treatment. With 26.8 million Americans, 8.2% of the U.S. population, affected by asthma in 2022, the need for innovative tools to support better care and disease management has never been greater.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><em>&#8220;We are incredibly proud of our collaboration with Allergy Partners and thrilled to help them implement the NObreath\u00ae FeNO technology\u201d, <\/em>said<strong> Jason Aversano, CEO at coVita&#x2122;.<\/strong><em>\u00a0 \u201cTheir determination to integrate FeNO testing across their entire network of providers is illustrative of their understanding of the vital role objective FeNO monitoring plays in the modern clinical setting.&#8221;<\/em><\/p>\n\n\n\n<p>Bedfont\u00ae Scientific, manufacturer of the NObreath\u00ae, and coVita&#x2122;, share a long-standing partnership grounded in mutual respect, trust, and a shared vision to improve respiratory health through innovation. Over the years, the two companies have worked hand in hand to make advanced breath analysis more accessible to clinicians and patients throughout the United States. Their collaboration continues to exemplify how aligned values and global cooperation can drive meaningful change in healthcare.<\/p>\n\n\n\n<p>To learn more about the NObreath\u00ae FeNO device, visit the website <a href=\"https:\/\/www.nobreathfeno.com\/\">here<\/a>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>References<\/strong><\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li>CDC. Most Recent Asthma Data [Internet]. Asthma Data. 2024. Available from: <a href=\"https:\/\/www.cdc.gov\/asthma-data\/about\/most-recent-asthma-data.html\">https:\/\/www.cdc.gov\/asthma-data\/about\/most-recent-asthma-data.html<\/a><\/li>\n<\/ol>\n<\/blockquote>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Innovative NObreath\u00ae FeNO device is the allergists&#8217; device of choice in the USA. coVita&#x2122; LLC, a leader in advanced breath analysis and diagnostic solutions, serves as the U.S. distributor for the innovative NObreath\u00ae Fractional Exhaled Nitric Oxide (FeNO) device from UK-based Bedfont\u00ae Scientific Ltd. The new agreement with Allergy Partners marks the culmination of a [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":10808,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[60],"tags":[167,9,157,166,168,154,169,155,156],"class_list":["post-10797","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bedfont-news","tag-allergy-partners","tag-bedfont-scientific","tag-breath-analysis","tag-covita","tag-feno","tag-feno-testing","tag-feno-usa","tag-improving-asthma-care","tag-nobreath"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NObreath\u00ae device is allergists&#039; device of choice in the USA.<\/title>\n<meta name=\"description\" content=\"coVita\u2122 and Allergy Partners team up to improve asthma care in America. NObreath\u00ae FeNO device is the allergists&#039; device of choice in the USA.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.bedfont.com\/nl\/nobreath-device-is-allergists-device-of-choice-in-the-usa\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NObreath\u00ae device is allergists&#039; device of choice in the USA.\" \/>\n<meta property=\"og:description\" content=\"coVita\u2122 and Allergy Partners team up to improve asthma care in America. NObreath\u00ae FeNO device is the allergists&#039; device of choice in the USA.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.bedfont.com\/nl\/nobreath-device-is-allergists-device-of-choice-in-the-usa\/\" \/>\n<meta property=\"og:site_name\" content=\"Bedfont Scientific Ltd.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Bedfontltd\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-13T14:30:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.bedfont.com\/wp-content\/uploads\/2025\/12\/Article-Featured-Images-9.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2240\" \/>\n\t<meta property=\"og:image:height\" content=\"1260\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"websites\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BedfontLtd\" \/>\n<meta name=\"twitter:site\" content=\"@BedfontLtd\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"websites\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/nobreath-device-is-allergists-device-of-choice-in-the-usa\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/nobreath-device-is-allergists-device-of-choice-in-the-usa\\\/\"},\"author\":{\"name\":\"websites\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/#\\\/schema\\\/person\\\/8d8a6df6af357a89254fe2e43e21b1f1\"},\"headline\":\"coVita&#x2122; and Allergy Partners team up to improve asthma care in America\",\"datePublished\":\"2026-01-13T14:30:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/nobreath-device-is-allergists-device-of-choice-in-the-usa\\\/\"},\"wordCount\":400,\"publisher\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/nobreath-device-is-allergists-device-of-choice-in-the-usa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bedfont.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Article-Featured-Images-9.png\",\"keywords\":[\"Allergy Partners\",\"Bedfont Scientific\",\"Breath analysis\",\"coVita\",\"FeNO\",\"FeNO Testing\",\"FeNO USA\",\"Improving asthma care\",\"NObreath\"],\"articleSection\":[\"Bedfont news\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/nobreath-device-is-allergists-device-of-choice-in-the-usa\\\/\",\"url\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/nobreath-device-is-allergists-device-of-choice-in-the-usa\\\/\",\"name\":\"NObreath\u00ae device is allergists' device of choice in the USA.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/nobreath-device-is-allergists-device-of-choice-in-the-usa\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/nobreath-device-is-allergists-device-of-choice-in-the-usa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bedfont.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Article-Featured-Images-9.png\",\"datePublished\":\"2026-01-13T14:30:00+00:00\",\"description\":\"coVita\u2122 and Allergy Partners team up to improve asthma care in America. NObreath\u00ae FeNO device is the allergists' device of choice in the USA.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/nobreath-device-is-allergists-device-of-choice-in-the-usa\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/nobreath-device-is-allergists-device-of-choice-in-the-usa\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/nobreath-device-is-allergists-device-of-choice-in-the-usa\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.bedfont.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Article-Featured-Images-9.png\",\"contentUrl\":\"https:\\\/\\\/www.bedfont.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Article-Featured-Images-9.png\",\"width\":2240,\"height\":1260,\"caption\":\"Innovative NObreath\u00ae FeNO device is the allergists' device of choice in the USA.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/nobreath-device-is-allergists-device-of-choice-in-the-usa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"coVita&#x2122; and Allergy Partners team up to improve asthma care in America\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/#website\",\"url\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/\",\"name\":\"Bedfont Scientific Ltd.\",\"description\":\"World leaders in breath analysis.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/#organization\",\"name\":\"Bedfont Scientific Ltd.\",\"url\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.bedfont.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/www.bedfont.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/logo.png\",\"width\":1600,\"height\":505,\"caption\":\"Bedfont Scientific Ltd.\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Bedfontltd\\\/\",\"https:\\\/\\\/x.com\\\/BedfontLtd\",\"https:\\\/\\\/www.instagram.com\\\/bedfontltd\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/bedfont-scientific-ltd\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/BedfontScientificLtd\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/#\\\/schema\\\/person\\\/8d8a6df6af357a89254fe2e43e21b1f1\",\"name\":\"websites\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3349652895ce7f1ab3d2a9e8b316a97b06ba43830084011df0c742bd2c90b853?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3349652895ce7f1ab3d2a9e8b316a97b06ba43830084011df0c742bd2c90b853?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3349652895ce7f1ab3d2a9e8b316a97b06ba43830084011df0c742bd2c90b853?s=96&d=mm&r=g\",\"caption\":\"websites\"},\"url\":\"https:\\\/\\\/www.bedfont.com\\\/nl\\\/author\\\/websites\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NObreath\u00ae device is allergists' device of choice in the USA.","description":"coVita\u2122 and Allergy Partners team up to improve asthma care in America. NObreath\u00ae FeNO device is the allergists' device of choice in the USA.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.bedfont.com\/nl\/nobreath-device-is-allergists-device-of-choice-in-the-usa\/","og_locale":"nl_NL","og_type":"article","og_title":"NObreath\u00ae device is allergists' device of choice in the USA.","og_description":"coVita\u2122 and Allergy Partners team up to improve asthma care in America. NObreath\u00ae FeNO device is the allergists' device of choice in the USA.","og_url":"https:\/\/www.bedfont.com\/nl\/nobreath-device-is-allergists-device-of-choice-in-the-usa\/","og_site_name":"Bedfont Scientific Ltd.","article_publisher":"https:\/\/www.facebook.com\/Bedfontltd\/","article_published_time":"2026-01-13T14:30:00+00:00","og_image":[{"width":2240,"height":1260,"url":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2025\/12\/Article-Featured-Images-9.png","type":"image\/png"}],"author":"websites","twitter_card":"summary_large_image","twitter_creator":"@BedfontLtd","twitter_site":"@BedfontLtd","twitter_misc":{"Geschreven door":"websites","Geschatte leestijd":"2 minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.bedfont.com\/nl\/nobreath-device-is-allergists-device-of-choice-in-the-usa\/#article","isPartOf":{"@id":"https:\/\/www.bedfont.com\/nl\/nobreath-device-is-allergists-device-of-choice-in-the-usa\/"},"author":{"name":"websites","@id":"https:\/\/www.bedfont.com\/nl\/#\/schema\/person\/8d8a6df6af357a89254fe2e43e21b1f1"},"headline":"coVita&#x2122; and Allergy Partners team up to improve asthma care in America","datePublished":"2026-01-13T14:30:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.bedfont.com\/nl\/nobreath-device-is-allergists-device-of-choice-in-the-usa\/"},"wordCount":400,"publisher":{"@id":"https:\/\/www.bedfont.com\/nl\/#organization"},"image":{"@id":"https:\/\/www.bedfont.com\/nl\/nobreath-device-is-allergists-device-of-choice-in-the-usa\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2025\/12\/Article-Featured-Images-9.png","keywords":["Allergy Partners","Bedfont Scientific","Breath analysis","coVita","FeNO","FeNO Testing","FeNO USA","Improving asthma care","NObreath"],"articleSection":["Bedfont news"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/www.bedfont.com\/nl\/nobreath-device-is-allergists-device-of-choice-in-the-usa\/","url":"https:\/\/www.bedfont.com\/nl\/nobreath-device-is-allergists-device-of-choice-in-the-usa\/","name":"NObreath\u00ae device is allergists' device of choice in the USA.","isPartOf":{"@id":"https:\/\/www.bedfont.com\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.bedfont.com\/nl\/nobreath-device-is-allergists-device-of-choice-in-the-usa\/#primaryimage"},"image":{"@id":"https:\/\/www.bedfont.com\/nl\/nobreath-device-is-allergists-device-of-choice-in-the-usa\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2025\/12\/Article-Featured-Images-9.png","datePublished":"2026-01-13T14:30:00+00:00","description":"coVita\u2122 and Allergy Partners team up to improve asthma care in America. NObreath\u00ae FeNO device is the allergists' device of choice in the USA.","breadcrumb":{"@id":"https:\/\/www.bedfont.com\/nl\/nobreath-device-is-allergists-device-of-choice-in-the-usa\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.bedfont.com\/nl\/nobreath-device-is-allergists-device-of-choice-in-the-usa\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.bedfont.com\/nl\/nobreath-device-is-allergists-device-of-choice-in-the-usa\/#primaryimage","url":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2025\/12\/Article-Featured-Images-9.png","contentUrl":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2025\/12\/Article-Featured-Images-9.png","width":2240,"height":1260,"caption":"Innovative NObreath\u00ae FeNO device is the allergists' device of choice in the USA."},{"@type":"BreadcrumbList","@id":"https:\/\/www.bedfont.com\/nl\/nobreath-device-is-allergists-device-of-choice-in-the-usa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.bedfont.com\/nl\/"},{"@type":"ListItem","position":2,"name":"coVita&#x2122; and Allergy Partners team up to improve asthma care in America"}]},{"@type":"WebSite","@id":"https:\/\/www.bedfont.com\/nl\/#website","url":"https:\/\/www.bedfont.com\/nl\/","name":"Bedfont Scientific Ltd.","description":"World leaders in breath analysis.","publisher":{"@id":"https:\/\/www.bedfont.com\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.bedfont.com\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/www.bedfont.com\/nl\/#organization","name":"Bedfont Scientific Ltd.","url":"https:\/\/www.bedfont.com\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.bedfont.com\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2023\/06\/logo.png","contentUrl":"https:\/\/www.bedfont.com\/wp-content\/uploads\/2023\/06\/logo.png","width":1600,"height":505,"caption":"Bedfont Scientific Ltd."},"image":{"@id":"https:\/\/www.bedfont.com\/nl\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Bedfontltd\/","https:\/\/x.com\/BedfontLtd","https:\/\/www.instagram.com\/bedfontltd\/","https:\/\/www.linkedin.com\/company\/bedfont-scientific-ltd\/","https:\/\/www.youtube.com\/user\/BedfontScientificLtd"]},{"@type":"Person","@id":"https:\/\/www.bedfont.com\/nl\/#\/schema\/person\/8d8a6df6af357a89254fe2e43e21b1f1","name":"websites","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/secure.gravatar.com\/avatar\/3349652895ce7f1ab3d2a9e8b316a97b06ba43830084011df0c742bd2c90b853?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3349652895ce7f1ab3d2a9e8b316a97b06ba43830084011df0c742bd2c90b853?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3349652895ce7f1ab3d2a9e8b316a97b06ba43830084011df0c742bd2c90b853?s=96&d=mm&r=g","caption":"websites"},"url":"https:\/\/www.bedfont.com\/nl\/author\/websites\/"}]}},"_links":{"self":[{"href":"https:\/\/www.bedfont.com\/nl\/wp-json\/wp\/v2\/posts\/10797","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bedfont.com\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bedfont.com\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bedfont.com\/nl\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bedfont.com\/nl\/wp-json\/wp\/v2\/comments?post=10797"}],"version-history":[{"count":3,"href":"https:\/\/www.bedfont.com\/nl\/wp-json\/wp\/v2\/posts\/10797\/revisions"}],"predecessor-version":[{"id":10983,"href":"https:\/\/www.bedfont.com\/nl\/wp-json\/wp\/v2\/posts\/10797\/revisions\/10983"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bedfont.com\/nl\/wp-json\/wp\/v2\/media\/10808"}],"wp:attachment":[{"href":"https:\/\/www.bedfont.com\/nl\/wp-json\/wp\/v2\/media?parent=10797"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bedfont.com\/nl\/wp-json\/wp\/v2\/categories?post=10797"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bedfont.com\/nl\/wp-json\/wp\/v2\/tags?post=10797"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}